128 related articles for article (PubMed ID: 19858060)
21. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P
Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemia.
Bühler A; Zenz T; Stilgenbauer S
Clin Cancer Res; 2010 Jan; 16(2):373-5. PubMed ID: 20068107
[TBL] [Abstract][Full Text] [Related]
23. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia.
Ferrer A; Ollila J; Tobin G; Nagy B; Thunberg U; Aalto Y; Vihinen M; Vilpo J; Rosenquist R; Knuutila S
Cancer Genet Cytogenet; 2004 Aug; 153(1):69-72. PubMed ID: 15325098
[TBL] [Abstract][Full Text] [Related]
24. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.
Donisi PM; Di Lorenzo N; Riccardi M; Paparella A; Sarpellon C; Zupo S; Bertoldero G; Minotto C; Stracca-Pansa V
Diagn Mol Pathol; 2006 Dec; 15(4):206-15. PubMed ID: 17122648
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients.
Tschumper RC; Geyer SM; Campbell ME; Kay NE; Shanafelt TD; Zent CS; Nowakowski GS; Call TG; Dewald GW; Jelinek DF
J Clin Invest; 2008 Jan; 118(1):306-15. PubMed ID: 18064298
[TBL] [Abstract][Full Text] [Related]
26. Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.
Widhopf GF; Goldberg CJ; Toy TL; Rassenti LZ; Wierda WG; Byrd JC; Keating MJ; Gribben JG; Rai KR; Kipps TJ
Blood; 2008 Mar; 111(6):3137-44. PubMed ID: 17675554
[TBL] [Abstract][Full Text] [Related]
27. Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
Lech-Maranda E; Grzybowska-Izydorczyk O; Wyka K; Mlynarski W; Borowiec M; Antosik K; Cebula-Obrzut B; Makuch-Lasica H; Nowak G; Klimkiewicz-Wojciechowska G; Wawrzyniak E; Bilinski P; Robak T; Warzocha K
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):477-86. PubMed ID: 22945689
[TBL] [Abstract][Full Text] [Related]
28. The origin of B-cell chronic lymphocytic leukemia.
Ghia P; Caligaris-Cappio F
Semin Oncol; 2006 Apr; 33(2):150-6. PubMed ID: 16616061
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity.
Mansouri M; Sevov M; Fahlgren E; Tobin G; Jondal M; Osorio L; Roos G; Olivecrona G; Rosenquist R
Leuk Res; 2010 Mar; 34(3):301-6. PubMed ID: 19709746
[TBL] [Abstract][Full Text] [Related]
30. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
[TBL] [Abstract][Full Text] [Related]
31. Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.
MacIntyre DA; Jiménez B; Lewintre EJ; Martín CR; Schäfer H; Ballesteros CG; Mayans JR; Spraul M; García-Conde J; Pineda-Lucena A
Leukemia; 2010 Apr; 24(4):788-97. PubMed ID: 20090781
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.
Rigoni M; Riganti C; Vitale C; Griggio V; Campia I; Robino M; Foglietta M; Castella B; Sciancalepore P; Buondonno I; Drandi D; Ladetto M; Boccadoro M; Massaia M; Coscia M
Oncotarget; 2015 Oct; 6(30):29833-46. PubMed ID: 26284584
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
34. Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.
Palma M; Parker A; Hojjat-Farsangi M; Forster J; Kokhaei P; Hansson L; Osterborg A; Mellstedt H
Exp Hematol; 2013 Jul; 41(7):615-26. PubMed ID: 23548418
[TBL] [Abstract][Full Text] [Related]
35. [Expression of stereotyped B-cell receptor and its clinical value in chronic lymphocytic leukemia].
Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Li CH; Qi JY; Qiu LG
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(46):3267-70. PubMed ID: 22333147
[TBL] [Abstract][Full Text] [Related]
36. Chronic lymphocytic leukemia patients with a V1-69 gene rearrangement do not have inferior survival with respect to patients that express other unmutated V(H) genes.
Panovska-Stavridis I; Ivanovski M; Siljanovski N; Cevreska L; Efremov DG
Leuk Res; 2007 Feb; 31(2):245-8. PubMed ID: 16797703
[TBL] [Abstract][Full Text] [Related]
37. Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia.
Koiso H; Yamane A; Mitsui T; Matsushima T; Tsukamoto N; Murakami H; Miyawaki S; Nojima Y; Karasawa M
Leuk Res; 2006 Mar; 30(3):272-6. PubMed ID: 16159662
[TBL] [Abstract][Full Text] [Related]
38. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
[TBL] [Abstract][Full Text] [Related]
39. Differential gene expression profile associated to apoptosis induced by dexamethasone in CLL cells according to IGHV/ZAP-70 status.
Baptista MJ; Muntañola A; Calpe E; Abrisqueta P; Salamero O; Fernández E; Codony C; Giné E; Kalko SG; Crespo M; Bosch F
Clin Cancer Res; 2012 Nov; 18(21):5924-33. PubMed ID: 22966019
[TBL] [Abstract][Full Text] [Related]
40. B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia.
Maura F; Visco C; Falisi E; Reda G; Fabris S; Agnelli L; Tuana G; Lionetti M; Guercini N; Novella E; Nichele I; Montaldi A; Autore F; Gregorini A; Barcellini W; Callea V; Mauro FR; Laurenti L; Foà R; Neri A; Rodeghiero F; Cortelezzi A
Am J Hematol; 2013 Jan; 88(1):32-6. PubMed ID: 23115077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
